1,2-二甲基-1,2,3,4-四氢异喹啉 | 14429-09-5

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 四氢异喹啉
• 中文名称: 1,2-二甲基-1,2,3,4-四氢异喹啉
• 英文名称: N-methyl-2-methyl-1,2,3,4-tetrahydroisoquinoline
• 英文别名: 1,2-dimethyl-1,2,3,4-tetrahydroisoquinoline；1,2-dimethyl-1,2,3,4-tetrahydro-isoquinoline；1,2-Dimethyl-1,2,3,4-tetrahydro-isochinolin；1,2-dimethyl-3,4-dihydro-1H-isoquinoline
• CAS: 14429-09-5
• 化学式: C₁₁H₁₅N
• mdl: MFCD24393052
• 分子量: 161.247
• InChiKey: ANEGOXNGPXRGPY-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.2
• 重原子数：
  12
• 可旋转键数：
  0
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.454
• 拓扑面积：
  3.2
• 氢给体数：
  0
• 氢受体数：
  1

安全信息

• 海关编码：
  2933499090

反应信息

• 作为反应物：
  描述：

  1,2-二甲基-1,2,3,4-四氢异喹啉 生成 tricarbonyl(η6-endo-1,2-dimethyl-1,2,3,4-tetrahydroisoquinoline)chromium(0)
  参考文献：
  名称：

  BLAGG J.; COOTE S. J.; DAVIES S. G.; MIDDLEMISS D.; NAYLOR A., J. CHEM. SOC. PERKIN TRANS.,(1987) N 3, 689-694

  摘要：

  DOI：
• 作为产物：
  描述：

  2-formyl-1,2,3,4-tetrahydro-1-methylisoquinoline 在 lithium aluminium tetrahydride 作用下， 以 四氢呋喃 为溶剂， 以89%的产率得到1,2-二甲基-1,2,3,4-四氢异喹啉
  参考文献：
  名称：

  A Highly Efficient Synthesis of 1-Methyl-, 1-Benzyl-, and 1-Phenyl-1,2,3,4-tetrahydroisoquinolines by a Modified Pummerer Reaction

  摘要：

  DOI：

  10.3987/com-97-s70

文献信息

• Modulators of Cystic Fibrosis Transmembrane Conductance Regulator
  申请人：VERTEX PHARMACEUTICALS INCORPORATED

  公开号：US20160095858A1

  公开（公告）日：2016-04-07

  The present invention features a compound of formula I: or a pharmaceutically acceptable salt thereof, where R 1 , R 2 , R 3 , W, X, Y, Z, n, o, p, and q are defined herein, for the treatment of CFTR mediated diseases, such as cystic fibrosis. The present invention also features pharmaceutical compositions, method of treating, and kits thereof.

  本发明涉及一种具有以下化学式I的化合物： 或其药用可接受的盐，其中R 1 ，R 2 ，R 3 ，W，X，Y，Z，n，o，p和q在此处定义，用于治疗CFTR介导的疾病，如囊性纤维化。本发明还涉及药物组合物、治疗方法和相关工具包。
• [EN] CYCLOHEXENE DERIVATIVE, PREPARATION METHOD THEREOF, AND PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING METABOLIC DISEASE COMPRISING THE SAME AS ACTIVE INGREDIENT<br/>[FR] DÉRIVÉ DE CYCLOHEXÈNE, SON PROCÉDÉ DE PRÉPARATION ET COMPOSITION PHARMACEUTIQUE POUR PRÉVENIR OU TRAITER UNE MALADIE MÉTABOLIQUE, CONTENANT LEDIT DÉRIVÉ COMME PRINCIPE ACTIF
  申请人：HYUNDAI PHARM CO LTD

  公开号：WO2017078352A1

  公开（公告）日：2017-05-11

  The present invention relates to: a cyclohexene derivative; a preparation method thereof; and a pharmaceutical composition for preventing or treating metabolic disease comprising the same as an active ingredient. The cyclohexene derivative according to the present invention increases the intracellular activity of cyclic adenosine monophosphate (cAMP) by activating G protein-coupled receptor 119 (GPR-119) and simultaneously exhibits weight loss and hypoglycemic effects by inducing the release of glucagon-like peptide-1 (GLP-1), which is a neuroendocrine protein, and thus can be useful as a pharmaceutical composition for preventing or treating metabolic diseases such as obesity, type 1 diabetes, type 2 diabetes, inadequate glucose tolerance, insulin resistance, hyperglycemia, hyperlipidemia, hypertriglyceridemia, hypercholesterolemia, dyslipidemia and syndrome X.

  本发明涉及：一种环己烯衍生物；其制备方法；以及一种包含该衍生物作为活性成分的用于预防或治疗代谢疾病的药物组合物。根据本发明的环己烯衍生物通过激活G蛋白偶联受体119（GPR-119）增加了细胞内环状腺苷一磷酸（cAMP）的活性，并通过诱导释放神经内分泌蛋白胰高血糖素样肽-1（GLP-1），同时表现出减肥和降糖效果，因此可作为预防或治疗诸如肥胖、1型糖尿病、2型糖尿病、葡萄糖耐量不足、胰岛素抵抗、高血糖、高脂血症、高甘油三酯血症、高胆固醇血症、血脂异常和综合征X等代谢疾病的药物组合物。
• Biphenyl-Substituted Cyclic Ketoenols
  申请人：FISCHER Reiner

  公开号：US20110230346A1

  公开（公告）日：2011-09-22

  The invention relates to novel compounds of the formula (I) in which W, X, Y, Z, and CKE have the meanings given above, to a plurality of processes and intermediates for their preparation and to their use as pesticides and/or herbicides and/or fungicides. Moreover, the invention relates to selectively herbicidal compositions comprising, firstly, the biphenyl-substituted cyclic ketoenols and, secondly, a crop plant compatibility-improving compound. The present invention furthermore relates to the boosting of the action of crop protection compositions comprising in particular biphenyl-substituted cyclic ketoenols through the addition of ammonium or phosphium salts and optionally penetrants, to the corresponding compositions, to processes for their preparation and to their use in crop protection as insecticides and/or nematicides and/or acaricides and/or fungicides and/or for preventing unwanted plant growth.

  该发明涉及以下式(I)的新化合物，其中W、X、Y、Z和CKE具有上述给定的含义，涉及它们的制备的多种过程和中间体，以及它们作为杀虫剂和/或除草剂和/或杀菌剂的用途。此外，该发明涉及包括第一，二苯基取代的环状酮烯醇和第二，一种改善作物植物相容性的化合物的选择性除草剂组合物。本发明还涉及通过添加铵盐或磷盐和可选的渗透剂，提高尤其是二苯基取代的环状酮烯醇的作物保护组合物的作用，以及相应的组合物、其制备的过程以及它们在作物保护中作为杀虫剂和/或线虫剂和/或螨虫剂和/或杀菌剂以及用于防止不受欢迎的植物生长的用途。
• NOVEL COMPOUNDS
  申请人：Gottschling Dirk

  公开号：US20110195954A1

  公开（公告）日：2011-08-11

  The present invention relates to new CGRP-antagonists of general formula I wherein U, V, X, Y, R 1 , R 2 , R 3 and R 4 are defined as mentioned in the description, the tautomers thereof, the isomers thereof, the diastereomers thereof, the enantiomers thereof, the hydrates thereof, the mixtures thereof and the salts thereof as well as the hydrates of the salts, particularly the physiologically acceptable salts thereof with inorganic or organic acids or bases, medicaments containing these compounds, the use thereof and processes for the preparation thereof.

  本发明涉及一般式I的新CGRP拮抗剂，其中U、V、X、Y、R1、R2、R3和R4如描述中所述定义，其互变异构体、异构体、顺反异构体、对映异构体、水合物、混合物及其盐，以及其盐的水合物，特别是与无机或有机酸或碱形成的生理上可接受的盐，包含这些化合物的药物、其用途以及其制备方法。
• Lewis acid complexed heteroatom carbanions; a new concept for α-metallation of tertiary amines
  作者：Satinder V. Kessar、Paramjit Singh、Rahul Vohra、Nachhattar Pal Kaur、Kamal Nain Singh

  DOI：10.1039/c39910000568

  日期：——

  BF3 complexes of typical benzylic, allylic and saturated N-methyl tertiary amines were α-lithiated, with lithium tetramethylpiperidide (LTMP) or sec-butyllithium, and were treated with electrophiles.

  典型的苄位、烯丙位和饱和N-甲基叔胺的BF3配合物在锂四甲基哌啶化物（LTMP）或仲丁基锂的作用下进行了α-锂化，并与亲电试剂反应。